AMPK Methods and Protocols

(Rick Simeone) #1
doi.org/10.1016/j.jacc.2006.10.073. S0735-
1097(07)00130-1 [pii]


  1. Massumi RA (1967) Familial Wolff-Parkinson-
    White syndrome with cardiomyopathy. Am J
    Med 43(6):951–955

  2. Westlake RE, Cohen W, Willis WH (1962)
    Wolff-Parkinson-White syndrome and familial
    cardiomegaly. Am Heart J 64:314–320

  3. Braunwald E, Morrow AG, Cornell WP, Aygen
    MM, Hilbish TF (1960) Idiopathic hypertro-
    phic subaortic stenosis. Am J Med 29
    (6):924–945. https://doi.org/10.1016/
    0002-9343(60)90074-7

  4. MacRae CA, Ghaisas N, Kass S, Donnelly S,
    Basson CT, Watkins HC, Anan R, Thierfelder
    LH, McGarry K, Rowland E et al (1995)
    Familial Hypertrophic cardiomyopathy with
    Wolff-Parkinson-White syndrome maps to a
    locus on chromosome 7q3. J Clin Invest 96
    (3):1216–1220. https://doi.org/10.1172/
    JCI118154

  5. Blair E, Redwood C, Ashrafian H, Oliveira M,
    Broxholme J, Kerr B, Salmon A, Ostman-
    Smith I, Watkins H (2001) Mutations in the
    gamma(2) subunit of AMP-activated protein
    kinase cause familial hypertrophic cardiomyop-
    athy: evidence for the central role of energy
    compromise in disease pathogenesis. Hum
    Mol Genet 10(11):1215–1220

  6. Lang T, Yu L, Tu Q, Jiang J, Chen Z, Xin Y,
    Liu G, Zhao S (2000) Molecular cloning,
    genomic organization, and mapping of
    PRKAG2, a heart abundant gamma2 subunit
    of 5^0 -AMP-activated protein kinase, to human
    chromosome 7q36. Genomics 70
    (2):258–263. https://doi.org/10.1006/
    geno.2000.6376. S0888-7543(00)96376-6
    [pii]

  7. Gollob MH, Green MS, Tang AS, Gollob T,
    Karibe A, Ali Hassan AS, Ahmad F, Lozado R,
    Shah G, Fananapazir L, Bachinski LL, Roberts
    R (2001) Identification of a gene responsible
    for familial Wolff-Parkinson-White syndrome.
    N Engl J Med 344(24):1823–1831.https://
    doi.org/10.1056/NEJM200106143442403

  8. Arad M, Benson DW, Perez-Atayde AR,
    McKenna WJ, Sparks EA, Kanter RJ,
    McGarry K, Seidman JG, Seidman CE (2002)
    Constitutively active AMP kinase mutations
    cause glycogen storage disease mimicking
    hypertrophic cardiomyopathy. J Clin Invest
    109(3):357–362. https://doi.org/10.1172/
    JCI14571

  9. Gollob MH, Green MS, Tang AS, Roberts R
    (2002) PRKAG2 cardiac syndrome: familial
    ventricular preexcitation, conduction system
    disease, and cardiac hypertrophy. Curr Opin
    Cardiol 17(3):229–234

  10. Ahmad F, Arad M, Musi N, He H, Wolf C,
    Branco D, Perez-Atayde AR, Stapleton D,
    Bali D, Xing Y, Tian R, Goodyear LJ, Berul
    CI, Ingwall JS, Seidman CE, Seidman JG
    (2005) Increased alpha2 subunit-associated
    AMPK activity and PRKAG2 cardiomyopathy.
    Circulation 112(20):3140–3148.https://doi.
    org/10.1161/CIRCULATIONAHA.105.

  11. CIRCULATIONAHA.105.550806
    [pii]

  12. Wolf CM, Arad M, Ahmad F, Sanbe A, Bern-
    stein SA, Toka O, Konno T, Morley G,
    Robbins J, Seidman JG, Seidman CE, Berul
    CI (2008) Reversibility of PRKAG2 glycogen-
    storage cardiomyopathy and electrophysiologi-
    cal manifestations. Circulation 117
    (2):144–154. https://doi.org/10.1161/
    CIRCULATIONAHA.107.726752. CIRCU-
    LATIONAHA.107.726752 [pii]

  13. Porto AG, Brun F, Severini GM, Losurdo P,
    Fabris E, Taylor MR, Mestroni L, Sinagra G
    (2016) Clinical spectrum of PRKAG2 syn-
    drome. Circ Arrhythm Electrophysiol 9(1):
    e003121. https://doi.org/10.1161/circep.
    115.003121

  14. Scott JW, Hawley SA, Green KA, Anis M,
    Stewart G, Scullion GA, Norman DG, Hardie
    DG (2004) CBS domains form energy-sensing
    modules whose binding of adenosine ligands is
    disrupted by disease mutations. J Clin Invest
    113(2):274–284. https://doi.org/10.1172/
    JCI19874

  15. Milan D, Jeon JT, Looft C, Amarger V,
    Robic A, Thelander M, Rogel-Gaillard C,
    Paul S, Iannuccelli N, Rask L, Ronne H,
    Lundstrom K, Reinsch N, Gellin J, Kalm E,
    Roy PL, Chardon P, Andersson L (2000) A
    mutation in PRKAG3 associated with excess
    glycogen content in pig skeletal muscle. Sci-
    ence 288(5469):1248–1251

  16. Costford SR, Kavaslar N, Ahituv N, Chaudhry
    SN, Schackwitz WS, Dent R, Pennacchio LA,
    McPherson R, Harper ME (2007) Gain-of-
    function R225W mutation in human AMPK-
    gamma(3) causing increased glycogen and
    decreased triglyceride in skeletal muscle. PLoS
    One 2(9):e903. https://doi.org/10.1371/
    journal.pone.0000903

  17. Richards S, Aziz N, Bale S, Bick D, Das S,
    Gastier-Foster J, Grody WW, Hegde M,
    Lyon E, Spector E, Voelkerding K, Rehm HL
    (2015) Standards and guidelines for the inter-
    pretation of sequence variants: a joint consen-
    sus recommendation of the American College
    of Medical Genetics and Genomics and the
    Association for Molecular Pathology. Genet
    Med 17(5):405–424. https://doi.org/10.
    1038/gim.2015.30


PRKAG2 syndrome 613
Free download pdf